Entering text into the input field will update the search result below

Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q2 2021 Results - Earnings Call Transcript

Aug. 03, 2021 9:15 PM ETNeurocrine Biosciences, Inc. (NBIX)
SA Transcripts profile picture
SA Transcripts

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q2 2021 Results Conference Call August 3, 2021 4:30 PM ET

Company Participants

Todd Tushla - VP, IR

Kevin Gorman - CEO

Matt Abernethy - CFO

Eiry Roberts - Chief Medical Officer

Eric Benevich - Chief Commercial Officer

Kyle Gano - Chief Business Development and Strategy Officer

Conference Call Participants

Tazeen Ahmad - Bank of America

Phil Nadeau - The Cowen Company

Paul Matteis - Stifel

Brian Abrahams - RBC Capital Markets

Brian Skorney - Baird

Jay Olson - Oppenheimer

Neena Bitritto-Garg - Citi

Anupam Rama - JP Morgan

David Amsellem - Piper Sandler

Chris Shibutani - Goldman Sachs

Charles Duncan - Cantor Fitzgerald

Vamil Divan - Mizuho

Josh Schimmer - Evercore

Myles Minter - William Blair

Danielle Brill - Raymond James

Laura Chico - Wedbush Securities

Eddie Hickman - Guggenheim


Good day, everyone, and welcome to today’s Neurocrine Biosciences Reports Second Quarter Results.

At this time, all participants are in a listen-only mode. Later, you’ll have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note, this call may be recorded. And I will be standing by, should you need any assistance.

It is now my pleasure to turn the conference over to your Vice President of Investor Relations, Todd Tushla. Please go ahead.

Todd Tushla

Thanks, Chloe. Good afternoon, and thank you for joining us on our second quarter 2021 earnings call.

On today’s call is Kevin Gorman, our Chief Executive Officer; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development and Strategy Officer.

During today’s call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to review the risk factors discussed

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.